Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This open trial aims to evaluate feasibility and preliminary effectiveness of an internet-delivered CBT-program for children and adolescents with functional gastrointestinal disorders when implemented in regular care.
Pain predominant functional gastrointestinal disorders (P-FGIDs) are common in children and adolescents and associated with impaired quality of life. Our research group have previously in a series of efficacy-studies shown that internet-delivered exposure-based CBT leads to reduced symptoms and increased quality of life in children and adolescents with P-FGIDs. There is therefore reason to investigate how the treatment should be disseminated in regular care. This open trial aim to evaluate feasibility and preliminary treatment effects in regular care of the internet-delivered CBT-program for children and adolescents with P-FGIDs.
Method: Open trial with a pretest-posttest-design and no control group. The internet-delivered CBT-program is 10 week long and include weekly therapist support, consisting of online messages and telephone calls. Assessment points are baseline, weekly during treatment, post-treatment and follow-up at 3 months and 6 months after treatment completion.
Analysis: Effect sizes and within-group differences will be calculated in an intent-to-treat analysis using Cohens' d and Student's t-test.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Internet-delivered CBT | Experimental | Exposure-based internet-delivered CBT with ten weekly modules distributed over the internet during ten weeks, and weekly therapist support over the internet. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Exposure-based internet-delivered CBT | Behavioral | The main target in treatment is exposure for abdominal symptoms by reducing avoidance and provoking symptoms. Participants are encouraged to gradually increase the difficulty by combining multiple challenges. The parents are taught how to reduce the risk for reinforcement of children's symptom behavior, and to support their child to complete the treatment. All treatment content is delivered over the internet, containing texts, videos, audio-files and examples. The modules are unlocked sequentially as participants worked their way through the treatment. Therapist support consists primarily of encouragement of any progress made in the treatment and support to find individual exercises. |
| Measure | Description | Time Frame |
|---|---|---|
| Global gastrointestinal symptoms (CSI-24: subscale 7 items on GI-symptoms). | Change in global gastrointestinal symptoms from baseline to 10 weeks. | Baseline to 10 weeks. |
| Measure | Description | Time Frame |
|---|---|---|
| Pain intensity (Faces Pain rating scale) | Change in pain intensity from baseline to 10 weeks | Baseline to 10 weeks |
| Pain intensity (Faces Pain rating scale) | Change in pain intensity from baseline to 3 months follow-up. |
| Measure | Description | Time Frame |
|---|---|---|
| Parental responses to children´s symptom behavior (ARCS) | Change in parental responses from baseline to 10 weeks. | Baseline to 10 weeks. |
| Parental responses to children´s symptom behavior (ARCS) | Change in parental responses from baseline to 3 months follow-up. |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Marianne Bonnert, PhD | Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Clinical Neuroscience, Karolinska Institutet | Stockholm | Sweden |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005767 | Gastrointestinal Diseases |
| D043183 | Irritable Bowel Syndrome |
| D004415 | Dyspepsia |
| ID | Term |
|---|---|
| D004066 | Digestive System Diseases |
| D003109 | Colonic Diseases, Functional |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
Not provided
Not provided
Open trial without control group to test feasibility and evaluate preliminary effects.
Not provided
Not provided
Not provided
Not provided
|
| Baseline to 5 months. |
| Pain intensity (Faces Pain rating scale) | Change in pain intensity from baseline to 6 months follow-up. | Baseline to 8 months. |
| Global gastrointestinal symptoms (CSI-24: subscale 7 items on GI-symptoms). | Change in global gastrointestinal symptoms from baseline to 3 months follow-up. | Baseline to 5 months. |
| Global gastrointestinal symptoms (CSI-24: subscale 7 items on GI-symptoms). | Change in global gastrointestinal symptoms from baseline to 6 months follow-up. | Baseline to 8 months. |
| Gastrointestinal symptoms module (PedsQL Gastro) | Change in different dimensions of gastrointestinal symptoms (e.g. pain-related symptoms, nausea, bloating) from baseline to 10 weeks. | Baseline to 10 weeks |
| Gastrointestinal symptoms module (PedsQL Gastro) | Change in different dimensions of gastrointestinal symptoms (e.g. pain-related symptoms, nausea, bloating) from baseline to 3 months follow up. | Baseline to 5 months. |
| Gastrointestinal symptoms module (PedsQL Gastro) | Change in different dimensions of gastrointestinal symptoms (e.g. pain-related symptoms, nausea, bloating) from baseline to 6 months follow up. | Baseline to 8 months. |
| Fear for symptoms (Visceral sensitivity index) | Change in fear for symptoms from baseline to 10 weeks. | Baseline to 10 weeks. |
| Fear for symptoms (Visceral sensitivity index) | Change in fear for symptoms from baseline to 3 months follow-up. | Baseline to 5 months. |
| Fear for symptoms (Visceral sensitivity index) | Change in fear for symptoms from baseline to 6 months follow-up. | Baseline to 8 months. |
| Avoidant behavior (IBS-BRQ) | Change in avoidant behavior from baseline to 10 weeks. | Baseline to 10 weeks |
| Avoidant behavior (IBS-BRQ) | Change in avoidant behavior from baseline to 3 months follow-up. | Baseline to 5 months. |
| Avoidant behavior (IBS-BRQ) | Change in avoidant behavior from baseline to 6 months follow-up. | Baseline to 8 months. |
| Quality of life (PedsQL) | Change in quality of life from baseline to 10 weeks. | Baseline to 10 weeks. |
| Quality of life (PedsQL) | Change in quality of life from baseline to 3 months follow-up. | Baseline to 5 months. |
| Quality of life (PedsQL) | Change in quality of life from baseline to 6 months follow-up. | Baseline to 8 months. |
| Baseline to 5 months. |
| Parental responses to children´s symptom behavior (ARCS) | Change in parental responses from baseline to 6 months follow-up. | Baseline to 8 months. |
| D012817 | Signs and Symptoms, Digestive |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |